FTP-002 is a medication being tested in this clinical trial to see how well it works and how safe it is for treating severe glabellar lines, which are the frown lines that appear between the eyebrows. This medication is given as a single injection into the muscle. The trial aims to find out if using FTP-002 alone can help reduce these lines and if it is safe for patients.

FTP-501 is another medication involved in the trial, also given as a single injection into the muscle. The purpose of testing FTP-501 is to evaluate its safety and how well it works when used in combination with FTP-002. The researchers want to see if adding FTP-501 to FTP-002 provides better results in reducing severe glabellar lines compared to using FTP-002 by itself.

Glabellar Lines – Glabellar lines are vertical wrinkles that appear between the eyebrows, often as a result of repeated facial expressions such as frowning. These lines are caused by the contraction of muscles in the forehead, specifically the corrugator and procerus muscles. Over time, these dynamic lines can become more pronounced and may persist even when the face is at rest. The progression of glabellar lines is influenced by factors such as age, skin type, and sun exposure. As the skin loses elasticity with age, these lines can deepen and become more noticeable. They are a common cosmetic concern and are often associated with an aged or tired appearance.